Insulin aspart, recombinant Subcutaneous and Perampanel Oral Suspension
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Perampanel Oral Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: perampanel
Brand name: Fycompa
Synonyms: Perampanel
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Perampanel Tablets
- Insulin aspart, recombinant Subcutaneous-Peranex HC
- Insulin aspart, recombinant Subcutaneous-Percocet
- Insulin aspart, recombinant Subcutaneous-Percocet 10/325
- Insulin aspart, recombinant Subcutaneous-Percocet 2.5/325
- Insulin aspart, recombinant Subcutaneous-Percocet 5/325
- Perampanel Oral Suspension-Insulin degludec
- Perampanel Oral Suspension-Insulin Degludec (U-100) Prefilled Pens
- Perampanel Oral Suspension-Insulin Degludec (U-100) Vials
- Perampanel Oral Suspension-Insulin Degludec (U-200) Prefilled Pens
- Perampanel Oral Suspension-Insulin degludec and liraglutide
- Perampanel Oral Suspension-Insulin degludec and liraglutide Subcutaneous